IL285763A - Solid polymorphs of a flna-binding compound and its hydrochloride salts - Google Patents

Solid polymorphs of a flna-binding compound and its hydrochloride salts

Info

Publication number
IL285763A
IL285763A IL285763A IL28576321A IL285763A IL 285763 A IL285763 A IL 285763A IL 285763 A IL285763 A IL 285763A IL 28576321 A IL28576321 A IL 28576321A IL 285763 A IL285763 A IL 285763A
Authority
IL
Israel
Prior art keywords
flana
binding compound
hydrochloride salts
polymorphs
solid
Prior art date
Application number
IL285763A
Other languages
English (en)
Hebrew (he)
Inventor
Zamloot Michael
Original Assignee
Pain Therapeutics Inc
Zamloot Michael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pain Therapeutics Inc, Zamloot Michael filed Critical Pain Therapeutics Inc
Publication of IL285763A publication Critical patent/IL285763A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL285763A 2019-02-21 2021-08-22 Solid polymorphs of a flna-binding compound and its hydrochloride salts IL285763A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962808609P 2019-02-21 2019-02-21
PCT/US2020/019305 WO2020172584A1 (en) 2019-02-21 2020-02-21 Solid polymorphs of a flna-binding compound and its hydrochloride salts

Publications (1)

Publication Number Publication Date
IL285763A true IL285763A (en) 2021-10-31

Family

ID=72141575

Family Applications (1)

Application Number Title Priority Date Filing Date
IL285763A IL285763A (en) 2019-02-21 2021-08-22 Solid polymorphs of a flna-binding compound and its hydrochloride salts

Country Status (10)

Country Link
US (4) US11370791B2 (cg-RX-API-DMAC7.html)
EP (1) EP3927707A4 (cg-RX-API-DMAC7.html)
JP (2) JP7895041B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210135530A (cg-RX-API-DMAC7.html)
CN (2) CN120004896A (cg-RX-API-DMAC7.html)
AU (1) AU2020224678B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021016622A2 (cg-RX-API-DMAC7.html)
CA (1) CA3131146A1 (cg-RX-API-DMAC7.html)
IL (1) IL285763A (cg-RX-API-DMAC7.html)
WO (1) WO2020172584A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2882428B1 (en) 2012-07-13 2019-01-16 Pain Therapeutics, Inc. A method of inhibiting tau phosphorylation
JP7895041B2 (ja) 2019-02-21 2026-07-27 フィラナ セラピューティクス インコーポレイテッド Flna結合化合物及びその塩酸塩の固体多形
WO2022098700A1 (en) * 2020-11-03 2022-05-12 Cassava Sciences, Inc. Inhibiting an immune response mediated by one or more of tlr2, rage, ccr5, cxcr4 and cd4

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004014304A1 (de) * 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8- Triazaspiro[4,5]decan-2-on-Verbindungen
US8614324B2 (en) * 2008-10-31 2013-12-24 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic
US8653068B2 (en) * 2009-10-30 2014-02-18 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic
US9340558B2 (en) * 2007-11-02 2016-05-17 Pain Therapeutics Inc. Filamin a binding anti-inflammatory and analgesic
EP2488177B1 (en) * 2008-10-31 2016-10-12 Pain Therapeutics, Inc. Filamin a binding anti-inflammatory and analgesic
WO2011119559A1 (en) * 2010-03-25 2011-09-29 Schering Corporation Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use
EP2882428B1 (en) * 2012-07-13 2019-01-16 Pain Therapeutics, Inc. A method of inhibiting tau phosphorylation
EP2872899B1 (en) 2012-07-13 2018-07-11 Pain Therapeutics, Inc. Alzheimer's disease assay in a living patient
US9433604B2 (en) 2013-10-08 2016-09-06 Pain Therapeutics Inc. Method for inhibiting growth of cancer cells
JP7895041B2 (ja) 2019-02-21 2026-07-27 フィラナ セラピューティクス インコーポレイテッド Flna結合化合物及びその塩酸塩の固体多形

Also Published As

Publication number Publication date
US20250084083A1 (en) 2025-03-13
CN114072406B (zh) 2025-03-18
BR112021016622A2 (pt) 2021-11-03
US20220340574A1 (en) 2022-10-27
US12391693B2 (en) 2025-08-19
JP2022523196A (ja) 2022-04-21
EP3927707A1 (en) 2021-12-29
CN114072406A (zh) 2022-02-18
US20200270250A1 (en) 2020-08-27
CN120004896A (zh) 2025-05-16
US11370791B2 (en) 2022-06-28
WO2020172584A1 (en) 2020-08-27
KR20210135530A (ko) 2021-11-15
AU2020224678B2 (en) 2024-03-14
US12065440B2 (en) 2024-08-20
CA3131146A1 (en) 2020-08-27
EP3927707A4 (en) 2022-11-09
JP7895041B2 (ja) 2026-07-27
NZ779310A (en) 2024-01-26
US20240400566A1 (en) 2024-12-05
JP2024054139A (ja) 2024-04-16
AU2020224678A1 (en) 2021-09-16

Similar Documents

Publication Publication Date Title
EP4083038A4 (en) PYRIDAZINYL THIAZOLECARBOXAMIDE COMPOUND
IL292753A (en) Compounds
IL283692A (en) Novel composition
IL283333A (en) New heterocyclic compounds
IL285461A (en) Processes and compounds
EP3922247A4 (en) 15-PGDH INHIBITOR
EP3919055A4 (en) HETEROCYCLIC COMPOUND
DK4055021T3 (da) Heterocykliske rip1-inhiberende forbindelser
EP4066893A4 (en) HETEROCYCLIC COMPOUND
EP4293025C0 (en) COMPOSED WITH 4-AMINOQUINAZOLINE
DK4043466T3 (da) PRC2-inhibitorer
DK4051688T3 (da) Cd73-hæmmere
IL286218A (en) Solid state forms of ripretinib
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
FIC20260011I1 (fi) nirogasestaatin dihydrobromidisuolan kiteinen muoto
EP3958454A4 (en) SOLID STATE TRANSFORMER
IL288034A (en) Compound for treating gout or hyperuricemia
EP4065456A4 (en) Mooring robot
PT3611171T (pt) Método para a síntese de eliglustato e dos seus compostos intermédios
IL285118A (en) Compounds and uses thereof
EP4003986A4 (en) Inhibitor compounds
EP3923473A4 (en) COMPARATOR
DK3808747T3 (da) Imidazopyridinon-forbindelse
MA53648A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase
DK3782986T3 (da) Heterocyklisk forbindelse